BMY $63.82 0.12 (0.2%)

    BMY Profile

    BMY trades on the NYSE.

    MEMBERSHIP
    S&P 500
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $151 Billion

    Large-Cap
    Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

    BMY Earnings

    EPS

    0.83

    P/E

    15.35

    Q2 Earnings for Apr, May & Jun

    Thu, Jul 25, 2019

    Since Earnings Report

    BMY +47.6%

    Q3 Earnings for Jul, Aug & Sep

    Thu, Oct 31, 2019

    Since Earnings Report

    BMY +12.2%

    BMY Dividend

    Dividend Yield

    2.82%

    Dividend Rate

    $1.80

    Ex-Dividend Date

    Thu, Jan 2, 2020

    Dividend Pay Date

    Mon, Feb 3, 2020

    Dividend Frequency

    Quarterly

    Dividend Payments

    1,906 Payments

    BMY Charts

    52WL $42.48
    52WH $64.75
    All-Time $77.12


    BMY Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Merck
    Pfizer
    Amgen
    Novo Nordisk A/S
    AbbVie
    Eli Lilly
    Sanofi SA (ADR)
    Gilead Sciences
    Celgene



    Symbol MC DY Price Day YTD
    BMY $150.73 2.82% $63.82 -0.2% 22.7%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy